We are live on ! Find out more
CCA

Catalyst Capital Advisors Portfolio holdings

AUM $6.03B
1-Year Est. Return 24.5%
This Fund
S&P 500
This Quarter Est. Return
+4.9%
1 Year Est. Return
+24.5%
3 Year Est. Return
+62.66%
5 Year Est. Return
+62.45%
10 Year Est. Return
+241.55%
AUM
$2.83B
AUM Growth
+$55.4M
Cap. Flow
-$48.7M
Cap. Flow %
-1.72%
Top 10 Hldgs %
61.04%
Holding
602
New
125
Increased
178
Reduced
65
Closed
116

Top Buys

Rank Stock Value
1
ILMN icon
Illumina
ILMN
+$17.3M
2
DINO icon
HF Sinclair
DINO
+$16.7M
3
KSS icon
Kohl's
KSS
+$14M
4
COP icon
ConocoPhillips
COP
+$13.3M
5
VALE icon
Vale
VALE
+$13M

Sector Composition

Rank Sector Weight
1 Energy 7.93%
2 Technology 4.8%
3 Financials 4.24%
4 Industrials 3.32%
5 Consumer Discretionary 2.66%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ITRM
401
DELISTED
Iterum Therapeutics
ITRM
$7K ﹤0.01%
+40
New +$7.22K
KNSA icon
402
Kiniksa Pharmaceuticals
KNSA
$4.83B
$7K ﹤0.01%
+404
New +$7.31K
PAGS icon
403
PagSeguro Digital
PAGS
$2.57B
$7K ﹤0.01%
253
+75
+42% +$2.48K
ROAD icon
404
Construction Partners
ROAD
$5.84B
$7K ﹤0.01%
+527
New +$6.64K
SRRK icon
405
Scholar Rock
SRRK
$5.71B
$7K ﹤0.01%
+465
New +$8.72K
UBX
406
DELISTED
Unity Biotechnology
UBX
$7K ﹤0.01%
+48
New +$7.02K
VICI icon
407
VICI Properties
VICI
$29.4B
$7K ﹤0.01%
337
+100
+42% +$1.93K
XERS icon
408
Xeris Biopharma Holdings
XERS
$1.44B
$7K ﹤0.01%
+373
New +$7.25K
QTTB icon
409
Q32 Bio
QTTB
$450M
$7K ﹤0.01%
18
+6
+50% +$2.15K
AIU
410
DELISTED
Meta Data Limited American Depositary Shares, each representing ten (10) Class A Ordinary Shares
AIU
$7K ﹤0.01%
5
+1
+25% +$1.48K
SURF
411
DELISTED
Surface Oncology, Inc. Common Stock
SURF
$7K ﹤0.01%
+440
New +$6.37K
EVLO
412
DELISTED
Evelo Biosciences, Inc. Common Stock
EVLO
$7K ﹤0.01%
+29
New +$8.46K
NEW
413
DELISTED
Puxin Limited American Depositary Shares, each representing twenty Ordinary Shares
NEW
$7K ﹤0.01%
+34
New +$7.8K
HUD
414
DELISTED
Hudson Ltd. Class A Common Shares
HUD
$7K ﹤0.01%
403
+125
+45% +$2.09K
SMTA
415
DELISTED
Spirit MTA REIT Common Shares of Beneficial Interest
SMTA
$7K ﹤0.01%
+700
New +$6.97K
AUTL
416
Autolus Therapeutics
AUTL
$386M
$6K ﹤0.01%
+224
New +$5.92K
EAF icon
417
GrafTech
EAF
$194M
$6K ﹤0.01%
+36
New +$6.57K
ECOR icon
418
electroCore
ECOR
$51.4M
$6K ﹤0.01%
+22
New +$5.98K
KYNB
419
Kyntra Bio
KYNB
$28.5M
$6K ﹤0.01%
+4
New +$5.21K
IR icon
420
Ingersoll Rand
IR
$33B
$6K ﹤0.01%
219
+56
+34% +$1.76K
MC icon
421
Moelis & Co
MC
$4.98B
$6K ﹤0.01%
97
+25
+35% +$1.44K
P
422
Everpure Inc
P
$24.8B
$6K ﹤0.01%
257
+76
+42% +$1.67K
STIM icon
423
Neuronetics
STIM
$120M
$6K ﹤0.01%
+240
New +$6.53K
VRCA icon
424
Verrica Pharmaceuticals
VRCA
$86.2M
$6K ﹤0.01%
+29
New +$5.68K
TECX
425
Tectonic Therapeutic
TECX
$573M
$6K ﹤0.01%
+17
New +$6.13K

Similar funds

Catalyst Capital Advisors's Q2 2018 Portfolio in Review

As of Q2 2018, Catalyst Capital Advisors held 602 positions worth $2.83B, up 2% from $2.78B the previous quarter. Its ten largest holdings account for 61% of the portfolio.

Catalyst Capital Advisors's Q2 2018 filing shows 125 new, 178 increased, 65 reduced and 116 closed positions. Its largest new stake was Illumina: 67,848 shares worth $18.4M. The largest sale was iShares Russell 2000 ETF, an estimated $31.8M.

By sector, the portfolio is most concentrated in Energy at 7.9% of assets, up from 5.6% a quarter earlier, followed by Technology and Financials.

  • Catalyst Capital Advisors's largest Q2 2018 buy was Illumina: 67,848 shares worth $18.4M.
  • Catalyst Capital Advisors added most to W.W. Grainger in Q2 2018, an estimated $7.28M increase.
  • Catalyst Capital Advisors's biggest Q2 2018 reduction was iShares Russell 2000 ETF, cutting an estimated $31.8M.
  • Catalyst Capital Advisors fully exited Teleflex in Q2 2018, selling an estimated $16.1M.
  • Catalyst Capital Advisors's ten largest holdings make up 61% of its $2.83B portfolio in Q2 2018.
  • Catalyst Capital Advisors opened 125 new positions and closed 116 in Q2 2018.
  • Catalyst Capital Advisors's portfolio value rose 2% quarter-over-quarter to $2.83B.

Based on Catalyst Capital Advisors's 13F filing for Q2 2018, filed 7 Aug 2018.